THIS ANNOUNCEMENT (INCLUDING THE
APPENDIX) AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART,
DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA,
CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER
JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A BREACH OF THE
RELEVANT SECURITIES LAWS OF SUCH JURISDICTION. PLEASE SEE THE
IMPORTANT NOTICES AT THE END OF THIS ANNOUNCEMENT.
THIS ANNOUNCEMENT IS FOR INFORMATION
PURPOSES AND DOES NOT CONSTITUTE A PROSPECTUS OR OFFERING
MEMORANDUM OR AN OFFER IN RESPECT OF ANY SECURITIES AND NEITHER
THIS ANNOUNCEMENT NOR THE FACT OF ITS DISTRIBUTION, FORMS OR IS
INTENDED TO FORM THE BASIS FOR ANY INVESTMENT DECISION IN RESPECT
OF MPAC GROUP PLC OR OTHER EVALUATION OF ANY SECURITIES OF MPAC
GROUP PLC OR ANY OTHER ENTITY AND SHOULD NOT BE CONSIDERED AS A
RECOMMENDATION THAT ANY INVESTOR SHOULD SUBSCRIBE FOR OR PURCHASE
ANY SUCH SECURITIES.
THIS ANNOUNCEMENT CONTAINS INSIDE
INFORMATION FOR THE PURPOSES OF THE UK VERSION OF THE MARKET ABUSE
REGULATION (EU NO. 596/2014) AS IT FORMS PART OF UNITED KINGDOM
DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018
("UK MAR"). IN
ADDITION, MARKET SOUNDINGS (AS DEFINED IN UK MAR) WERE TAKEN IN
RESPECT OF CERTAIN OF THE MATTERS CONTAINED IN THIS ANNOUNCEMENT,
WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF SUCH INSIDE
INFORMATION, AS PERMITTED BY UK MAR. UPON THE PUBLICATION OF THIS
ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN
THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN
POSSESSION OF INSIDE INFORMATION.
For immediate release
1 October 2024
Mpac Group
plc
Proposed Placing to raise
£29 million
Proposed Retail Offer to
raise up to £1 million
Mpac Group plc ("Mpac" or the
"Company") (AIM:
MPAC), the AIM quoted global leader in high-speed
packaging and automation solutions, announces a proposed
conditional placing of 7,250,000 new ordinary shares of 25 pence each (the
"Ordinary Shares") in the
capital of the Company (the "Placing Shares") at a price of
400 pence per Placing Share (the
"Issue Price") to raise
gross proceeds (before fees and expenses) of £29
million (the "Placing").
The Placing Shares will represent
approximately 33.7 per cent. of the existing issued ordinary share
capital of the Company (the "Existing Ordinary Shares") and the
Issue Price represents a discount of approximately 3.6 per cent. to
the closing mid-market price of 415
pence per Existing Ordinary Share on 30 September
2024, being the latest practicable date prior to the publication of
this Announcement.
Mpac proposes to use the net
proceeds of the Placing to partly fund the cash consideration
payable by the Company for the conditional acquisition of a
leading provider of design, manufacturing and
installation services for end-of-line automation and palletising
solutions, CSi Palletising (the "Acquisition"), as announced by Mpac
separately earlier today (the "Acquisition Announcement").
Mpac also intends to carry out a
separate retail offer of up to 250,000 new
Ordinary Shares (the "Retail Offer
Shares", and together with the Placing Shares, the
"New Ordinary Shares") at
the Issue Price on the Bookbuild Platform to raise gross proceeds
(before fees and expenses) of up to £1 million (the "Retail Offer", and together with the
Placing, the "Fundraising"). The Retail Offer will
provide existing retail Shareholders in the United Kingdom with an
opportunity to participate in the Fundraising at the same price as
the Placing. A separate announcement will be made in due
course regarding the Retail Offer and its terms. For the avoidance
of doubt, the Retail Offer is not part of the Placing.
It is expected that the Fundraising
will result in the Company raising total gross proceeds (before
fees and expenses) of up to £30 million.
A circular (the "Circular"), containing details of the
Fundraising and the Acquisition and convening a general meeting of
the Company proposed to be held at the offices of Mpac, 2 Argosy
Court, Coventry, CV3 4GA at 9.00 a.m. on 18 October 2024 (the
"General Meeting") in order
to pass the resolutions (the "Resolutions"), is expected to be posted
to Shareholders after the closure of the Bookbuild (as defined
below). The Circular, once published, will be available on the
Company's website at www.Mpac-group.com.
Unless the context otherwise provides, capitalised terms used
in this announcement (including the appendix (the "Appendix" and
together, this "Announcement")) have the meanings ascribed to them
in the section headed "Definitions" at the end of this
Announcement.
Details of the Placing
Shore Capital Stockbrokers Limited
("SCS") and Panmure Liberum
Limited (together with SCS, the "Joint Bookrunners") are acting as joint
bookrunners in connection with the Placing
and Shore Capital and Corporate Limited ("SCC", and together with SCS,
"Shore Capital") is acting
as nominated adviser to Mpac.
The Placing will be effected by way
of an accelerated bookbuild (the "Bookbuild") at the Issue Price. The
Bookbuild will open with immediate effect following the release of
this Announcement in accordance with the
terms and conditions set out in the Appendix.
The Placing is conditional
upon, inter alia, the
passing of the Resolutions and the Placing Agreement between the
Company and the Joint Bookrunners not having been terminated in
accordance with its terms.
The Placing is not conditional on
the completion of the Acquisition. The conditions to the completion
of the Acquisition are set out in the Acquisition Announcement and
include the Acquisition having become unconditionally authorised
from a national security perspective by a decision of the Romanian
Competition Council pursuant to Government Emergency Ordinance no.
46/2022 on terms that are reasonably satisfactory to Mpac Bidco,
the Resolutions being duly passed and the consultation procedures
with the works council established at the level of CSi Industries
B.V. in accordance with article 25 of the Dutch Works Council Act
(Wet op de
ondernemingsraden) having been complied with. In the
unlikely event the Acquisition does not complete, the Company may,
at its option, decide to use the funds for alternative investments
or consider a tax efficient way to return the net proceeds to
Shareholders. The Retail Offer is conditional on the Placing but the Placing is not conditional on the
Retail Offer.
The timing for the close of the
Bookbuild and allocation of the Placing Shares shall be at the
absolute discretion of the Joint Bookrunners, in consultation with
the Company. The final number of Placing Shares to be issued
pursuant to the Placing will be agreed by the Joint Bookrunners and
the Company at the close of the Bookbuild. The result of the
Placing will be announced as soon as practicable thereafter. The
Placing is not being underwritten. The Placing
Shares are not part of the Retail Offer.
Directors' participation in the Placing
The following Directors have
indicated that they intend to participate in the Placing as set out
below. Further details will be set out in the announcement
regarding the results of the Placing.
Director
|
Position
|
Amount (£)
|
|
Andrew
Kitchingman
|
Non-executive Chairman
|
10,000
|
|
Adam
Holland
|
Chief
Executive Officer
|
20,000
|
|
William
Wilkins
|
Group
Finance Director
|
20,000
|
|
Sara
Fowler
|
Non-executive Director
|
20,000
|
|
Matthew
Taylor
|
Non-executive Director
|
20,000
|
|
Total
|
|
90,000
|
|
Admission, settlement and dealings
Application will be made to the
London Stock Exchange for the New Ordinary Shares to be admitted to
trading on the AIM market of the London Stock Exchange
("Admission").
Admission is expected to take place
at 8.00 a.m. on 21 October 2024 and dealings in the New Ordinary
Shares are expected to commence at 8.00 a.m. on 21
October 2024 or, in each case, such later time and/or date
as the Joint Bookrunners and the Company agree (being in any event
no later than 8.00 a.m. on 28 October
2024).
The New Ordinary Shares, when
issued, will be credited as fully paid and will rank pari passu in all respects with the
Existing Ordinary Shares, including the right to receive all
dividends and other distributions declared, made or paid after the
date of issue.
The New Ordinary Shares will be in
registered form and will be capable of being held in either
certificated or uncertificated form (i.e. in CREST). Accordingly,
following Admission, settlement of transactions in the Ordinary
Shares may take place within the CREST system if a Shareholder so
wishes. Shareholders who wish to receive and retain share
certificates are able to do so.
The ISIN number of the New Ordinary
Shares is GB0005991111. The TIDM is MPAC.
This Announcement should be read in its entirety. In
particular, you should read and understand the information provided
in the "Important Notices" section of this Announcement. The
Appendix to this Announcement sets out further information relating
to the terms and conditions of the Placing. It is intended that the
Retail Offer Shares will be subscribed for on the basis of the
terms and conditions of the Retail Offer, rather than pursuant to
the terms and conditions of the Placing contained in the Appendix
to this Announcement.
The person responsible for arranging
the release of this Announcement on behalf of the Company is
William Wilkins, Group Finance Director of the Company.
For
further information please contact:
Mpac Group plc
Adam Holland, Chief
Executive
Will Wilkins, Group Finance
Director
|
Tel: +44 (0) 24 7642 1100
|
Shore Capital (Nominated Adviser, Joint Broker and Joint
Bookrunner)
Advisory
Patrick Castle/Sophie
Collins
Broking
Henry Willcocks
|
Tel: +44 (0) 20 7408 4050
|
Panmure Liberum (Joint Broker and Joint
Bookrunner)
Edward Mansfield
Will King
Anake Singh
Hudson Sandler
Nick Lyon
Nick Moore
Francesca Rosser
|
Tel: +44 (0) 20 3100 2000
Tel: +44 (0) 20 7796 4133
|
|
|
EXPECTED TIMETABLE OF
PRINCIPAL EVENTS
Announcement of the Acquisition
|
|
Announcement of the Placing
|
1 October
2024
|
Announcement of the Retail Offer
|
1 October
2024
|
Announcement of the results of the Placing
|
1 October
2024
|
Publication
of the Circular
|
2 October
2024
|
Announcement of the results of the Retail Offer
|
8 October
2024
|
Latest time
and date for receipt of completed proxy appointments and CREST
voting instructions
|
9.00 a.m.
on 16 October 2024
|
General
Meeting
|
9.00 a.m. on 18 October 2024
|
Announcement of results of General Meeting
|
18 October
2024
|
Admission
and commencement of dealings in the New Ordinary Shares on
AIM
|
8.00 a.m.
on 21 October 2024
|
Where
applicable, expected date for crediting of the New Ordinary Shares
in uncertificated form to CREST accounts
|
As soon as
possible following First Admission
|
Where
applicable, expected date for despatch of share certificates in
respect of the New Ordinary Shares
|
within 10
Business Days of
First Admission
|
Notes:
1.
All references to times in this Announcement are
to London time.
2.
The dates and times set out in the above timetable
and in the rest of this Announcement are indicative only and may be
subject to change. If any such dates and times should change, the
revised times and/or dates will be notified by the Company by announcement via a Regulatory Information
Service.
3.
All events in the above timetable scheduled to
take place after the General Meeting are conditional on the
approval by the Shareholders of the Resolutions.
Important
Notices
Shore Capital is authorised and
regulated by the Financial Conduct Authority (the "FCA") in the United Kingdom and is
acting exclusively for Mpac and no one else in connection with the
Placing, and Shore Capital will not be responsible to anyone
(including any Placees) other than Mpac for providing the
protections afforded to its clients or for providing advice in
relation to the Placing or any other matters referred to in this
Announcement.
Panmure Liberum is authorised and
regulated by the FCA in the United Kingdom and is acting
exclusively for Mpac and no one else in connection with the
Placing, and Panmure Liberum will not be responsible to anyone
(including any Placees) other than Mpac for providing the
protections afforded to its clients or for providing advice in
relation to the Placing or any other matters referred to in this
Announcement.
No representation or warranty,
express or implied, is or will be made as to, or in relation to,
and no responsibility or liability is or will be accepted by the
Joint Bookrunners or by any of their respective Representatives as
to, or in relation to, the accuracy or completeness of this
Announcement or any other written or oral information made
available to or publicly available to any interested party or its
advisers, and any liability therefore is expressly
disclaimed.
The responsibilities of SCC as
Mpac's nominated adviser under the AIM Rules for Nominated Advisers
are owed solely to the London Stock Exchange and are not owed to
Mpac or to any Director or to any other person.
This Announcement may contain, or
may be deemed to contain, "forward-looking statements" with respect
to certain of Mpac's plans and its current goals and expectations
relating to its future financial condition, performance, strategic
initiatives, objectives and results. Forward-looking statements
sometimes use words such as "aim", "anticipate", "target",
"expect", "estimate", "intend", "plan", "goal", "believe", "seek",
"may", "could", "outlook" or other words of similar meaning. By
their nature, all forward-looking statements involve risk and
uncertainty because they relate to future events and circumstances
which are beyond the control of Mpac, including amongst other
things, United Kingdom domestic and global economic business
conditions, market-related risks such as fluctuations in interest
rates and exchange rates, the policies and actions of governmental
and regulatory authorities, the effect of competition, inflation,
deflation, the timing effect and other uncertainties of future
acquisitions or combinations within relevant industries, the effect
of tax and other legislation and other regulations in the
jurisdictions in which Mpac and its affiliates operate, the effect
of volatility in the equity, capital and credit markets on Mpac's
profitability and ability to access capital and credit, a decline
in Mpac's credit ratings; the effect of operational risks; and the
loss of key personnel. As a result, the actual future financial
condition, performance and results of Mpac may differ materially
from the plans, goals and expectations set forth in any
forward-looking statements. Any forward-looking statements made in
this Announcement by or on behalf of Mpac speak only as of the date
they are made. Except as required by applicable law or regulation,
Mpac expressly disclaims any obligation or undertaking to publish
any updates or revisions to any forward-looking statements
contained in this Announcement to reflect any changes in Mpac's
expectations with regard thereto or any changes in events,
conditions or circumstances on which any such statement is
based.
No statement in this Announcement is
intended to be a profit forecast or estimate, and no statement in
this Announcement should be interpreted to mean that earnings per
share of Mpac for the current or future financial years would
necessarily match or exceed the historical published earnings per
share of Mpac.
The Placing Shares to be issued
pursuant to the Placing will not be admitted to trading on any
stock exchange other than the AIM market of the London Stock
Exchange.
Investors who have chosen to
participate in the Bookbuild and the Placing, by making or
accepting an oral, electronic or written and legally binding offer
to acquire Placing Shares, will be deemed to have read and
understood this Announcement in its entirety and to be making an
offer and acquiring the Placing Shares on the terms and subject to
the conditions contained herein and to be providing the
confirmations, representations, warranties, agreements,
acknowledgements and undertakings contained in the
Appendix.
The Placing Shares have not been
approved or disapproved by the US Securities and Exchange
Commission, any state securities commission or other regulatory
authority in the United States, nor have any of the foregoing
authorities passed upon or endorsed the merits of the Placing or
the accuracy or adequacy of this Announcement. Any representation
to the contrary is a criminal offence in the United States. The
relevant clearances have not been, nor will they be, obtained from
the securities commission of any province or territory of Canada,
no prospectus has been lodged with, or registered by, the
Australian Securities and Investments Commission or the Japanese
Ministry of Finance; the relevant clearances have not been, and
will not be, obtained from the South Africa Reserve Bank or any
other applicable body in the Republic of South Africa in relation
to the Placing Shares; and the Placing Shares have not been, nor
will they be, registered under or offered in compliance with the
securities laws of any state, province or territory of the United
States, Australia, Canada, the Republic of South Africa or
Japan. Accordingly, the Placing Shares may not (unless an
exemption under the relevant securities laws is applicable) be
offered, sold, resold or delivered, directly or indirectly, in or
into the United States, Australia, Canada, the Republic of South
Africa or Japan or any other jurisdiction outside the United
Kingdom or the EEA.
Neither the content of Mpac's
website nor any website accessible by hyperlinks on the Company's
website is incorporated in, or forms part of, this
Announcement.
INFORMATION TO
DISTRIBUTORS
UK product
governance
Solely for the purposes of the product governance requirements
contained within Chapter 3 of the FCA Handbook Product Intervention
and Product Governance Sourcebook (the "UK Product Governance
Requirements"), and disclaiming all and any liability, whether
arising in tort, contract or otherwise, which any "manufacturer"
(for the purposes of the UK Product Governance Requirements) may
otherwise have with respect thereto, the Placing Shares have been
subject to a product approval process, which has determined that
such securities are: (i) compatible with an end target market of
investors who meet the criteria of retail investors and investors
who meet the criteria of professional clients and eligible
counterparties, each as defined in paragraph 3 of the FCA Handbook
Conduct of Business Sourcebook; and (ii) eligible for distribution
through all distribution channels (the "Target Market Assessment").
Notwithstanding the Target Market Assessment, distributors (for the
purposes of UK Product Governance Requirements) should note that:
(a) the price of the Placing Shares may decline and investors could
lose all or part of their investment; (b) the Placing Shares offer
no guaranteed income and no capital protection; and (c) an
investment in the Placing Shares is compatible only with investors
who do not need a guaranteed income or capital protection, who
(either alone or in conjunction with an appropriate financial or
other adviser) are capable of evaluating the merits and risks of
such an investment and who have sufficient resources to be able to
bear any losses that may result therefrom. The Target Market
Assessment is without prejudice to the requirements of any
contractual, legal or regulatory selling restrictions in relation
to the Placing. Furthermore, it is noted that, notwithstanding the
Target Market Assessment, the Joint Bookrunners will only procure
investors who meet the criteria of professional clients and
eligible counterparties.
For
the avoidance of doubt, the Target Market Assessment does not
constitute: (a) an assessment of suitability or appropriateness for
the purposes of Chapter 9A or 10A respectively of the FCA Handbook
Conduct of Business Sourcebook; or (b) a recommendation to any
investor or group of investors to invest in, or purchase, or take
any other action whatsoever with respect to the Placing
Shares.
Each distributor is responsible for undertaking its own target
market assessment in respect of the Placing Shares and determining
appropriate distribution channels.
EEA product
governance
Solely for the purposes of the product governance requirements
contained within: (a) EU Directive 2014/65/EU on markets in
financial instruments, as amended ("MiFID II"); (b) Articles 9 and
10 of Commission Delegated Directive (EU) 2017/593 supplementing
MiFID II; and (c) local implementing measures in the European
Economic Area (together, the "MiFID II Product Governance
Requirements"), and disclaiming all and any liability, whether
arising in tort, contract or otherwise, which any "manufacturer"
(for the purposes of the MiFID II Product Governance Requirements)
may otherwise have with respect thereto, the Placing Shares have
been subject to a product approval process, which has determined
that the Placing Shares are: (i) compatible with an end target
market of (a) retail investors, (b) investors who meet the criteria
of professional clients and (c) eligible counterparties, each as
defined in MiFID II; and (ii) eligible for distribution through all
distribution channels as are permitted by MiFID II (the "EU Target
Market Assessment"). Notwithstanding the EU Target Market
Assessment, distributors should note that: the price of the Placing
Shares may decline and investors could lose all or part of their
investment; the Placing Shares offer no guaranteed income and no
capital protection; and an investment in the Placing Shares is
compatible only with investors who do not need a guaranteed income
or capital protection, who (either alone or in conjunction with an
appropriate financial or other adviser) are capable of evaluating
the merits and risks of such an investment and who have sufficient
resources to be able to bear any losses that may result therefrom.
The Target Market Assessment is without prejudice to the
requirements of any contractual, legal or regulatory selling
restrictions in relation to the Placing. Furthermore, it is noted
that, notwithstanding the EU Target Market Assessment, the Joint
Bookrunners will only procure investors who meet the criteria of
professional clients and eligible counterparties.
For
the avoidance of doubt, the EU Target Market Assessment does not
constitute: (a) an assessment of suitability or appropriateness for
the purposes of MiFID II; or (b) a recommendation to any investor
or group of investors to invest in, or purchase, or take any other
action whatsoever with respect to the Placing
Shares.
Each distributor is responsible for undertaking its own target
market assessment in respect of the Placing Shares and determining
appropriate distribution channels.
APPENDIX
TERMS AND CONDITIONS OF THE
PLACING
IMPORTANT INFORMATION ON THE PLACING
FOR INVITED PLACEES ONLY.
MEMBERS OF THE PUBLIC ARE NOT
ELIGIBLE TO TAKE PART IN THE PLACING. THIS ANNOUNCEMENT (INCLUDING
THIS APPENDIX) AND THE TERMS AND CONDITIONS SET OUT HEREIN
(TOGETHER, THIS "ANNOUNCEMENT") ARE DIRECTED ONLY AT
PERSONS WHOSE ORDINARY ACTIVITIES INVOLVE THEM IN ACQUIRING,
HOLDING, MANAGING AND DISPOSING OF INVESTMENTS (AS PRINCIPAL OR
AGENT) FOR THE PURPOSES OF THEIR BUSINESS AND WHO HAVE PROFESSIONAL
EXPERIENCE IN MATTERS RELATING TO INVESTMENTS AND ARE: (A) IF IN A
MEMBER STATE ("RELEVANT MEMBER
STATE") OF THE EUROPEAN ECONOMIC AREA ("EEA"), PERSONS WHO ARE QUALIFIED
INVESTORS ("EEA QUALIFIED
INVESTORS"), BEING PERSONS FALLING WITHIN THE MEANING OF
ARTICLE 2(e) OF REGULATION (EU) 2017/1129 (THE "EU PROSPECTUS REGULATION"); OR (B) IF
IN THE UNITED KINGDOM, PERSONS WHO ARE QUALIFIED INVESTORS
("UK QUALIFIED INVESTORS"),
BEING PERSONS FALLING WITHIN THE MEANING OF ARTICLE 2(e) OF THE EU
PROSPECTUS REGULATION AS IT FORMS PART OF DOMESTIC LAW BY VIRTUE OF
THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (THE "UK PROSPECTUS REGULATION"), AND WHO
ARE: (I) PERSONS FALLING WITHIN THE DEFINITION OF AN "INVESTMENT
PROFESSIONAL" IN ARTICLE 19(5) OF THE FINANCIAL SERVICES AND
MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (THE
"ORDER"); OR (II) PERSONS
WHO FALL WITHIN ARTICLE 49(2)(A) TO (D) (HIGH NET WORTH COMPANIES,
UNINCORPORATED ASSOCIATIONS, ETC) OF THE ORDER; OR (C) PERSONS TO
WHOM IT MAY OTHERWISE BE LAWFULLY COMMUNICATED (ALL SUCH PERSONS
REFERRED TO IN (A), (B) AND (C) TOGETHER BEING REFERRED TO AS
"RELEVANT
PERSONS").
THIS ANNOUNCEMENT AND THE
INFORMATION SET OUT HEREIN MUST NOT BE ACTED ON OR RELIED ON BY
PERSONS WHO ARE NOT RELEVANT PERSONS. PERSONS DISTRIBUTING THIS
ANNOUNCEMENT MUST SATISFY THEMSELVES THAT IT IS LAWFUL TO DO SO.
ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS ANNOUNCEMENT
RELATES IS AVAILABLE ONLY TO RELEVANT PERSONS AND WILL BE ENGAGED
IN ONLY WITH RELEVANT PERSONS. THIS ANNOUNCEMENT DOES NOT ITSELF
CONSTITUTE AN OFFER FOR THE SALE OR SUBSCRIPTION OF ANY SECURITIES
IN THE COMPANY.
THE PLACING SHARES HAVE NOT BEEN AND
WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF
1933, AS AMENDED (THE "SECURITIES
ACT") OR WITH ANY SECURITIES REGULATORY AUTHORITY OF ANY
STATE OR JURISDICTION OF THE UNITED STATES, AND MAY NOT BE OFFERED,
SOLD OR TRANSFERRED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED
STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE
UNITED STATES AND THE DISTRICT OF COLUMBIA) EXCEPT PURSUANT TO AN
EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE
REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN COMPLIANCE
WITH ANY APPLICABLE SECURITIES LAWS OF ANY STATE OR ANY OTHER
JURISDICTION OF THE UNITED STATES. ACCORDINGLY, THE PLACING SHARES
WILL BE OFFERED AND SOLD ONLY OUTSIDE OF THE UNITED STATES IN
"OFFSHORE TRANSACTIONS" (AS
SUCH TERM IS DEFINED IN REGULATION S UNDER THE SECURITIES ACT
("REGULATION S")) PURSUANT
TO REGULATION S AND OTHERWISE IN ACCORDANCE WITH APPLICABLE LAWS.
NO PUBLIC OFFERING OF THE PLACING SHARES IS BEING MADE IN THE
UNITED STATES OR ELSEWHERE.
THIS ANNOUNCEMENT (INCLUDING THE
APPENDIX) AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART,
DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES,
AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER
JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION
WOULD BE UNLAWFUL.
THIS ANNOUNCEMENT IS NOT AN OFFER OF
SECURITIES FOR SALE OR SUBSCRIPTION INTO THE UNITED STATES. THE
SECURITIES REFERRED TO HEREIN HAVE NOT BEEN AND WILL NOT BE
REGISTERED UNDER THE SECURITIES ACT AND MAY NOT BE OFFERED OR SOLD
IN THE UNITED STATES, EXCEPT PURSUANT TO AN APPLICABLE EXEMPTION
FROM REGISTRATION. NO PUBLIC OFFERING IS BEING MADE IN THE UNITED
STATES.
The distribution of this
Announcement and/or the Placing and/or issue of the Placing Shares
in certain jurisdictions may be restricted by law. No action has
been taken or will be taken by the Company, the Nominated Adviser,
the Joint Bookrunners or any of their respective affiliates,
agents, directors, officers or employees that would permit an offer
of the Placing Shares or possession or distribution of this
Announcement or any other offering or publicity material relating
to such Placing Shares in any jurisdiction where action for that
purpose is required. Persons into whose possession this
Announcement comes are required by the Company, the Nominated
Adviser, and the Joint Bookrunners to inform themselves about and
to observe any such restrictions.
Neither this Announcement nor any
part of it constitutes or forms part of any offer to issue or sell,
or the solicitation of an offer to acquire, purchase or subscribe
for, any securities in any jurisdiction in which such offer or
solicitation is unlawful and, in particular, is not for
distribution in or into the United States (including its
territories and possessions, any state of
the United States and the District of Columbia), Australia, Canada,
Japan, the Republic of South Africa or to any national, resident or
citizen of the United States, Australia, Canada, Japan or the
Republic of South Africa or to any corporation, partnership or
other entity created or organized under the laws thereof, or to any
persons in any other country outside the United Kingdom where such
distribution may lead to a breach of any legal or regulatory
requirement. No public offering of the Placing Shares is being made
in any such jurisdiction.
All offers of the Placing Shares in
the United Kingdom or the EEA will be made pursuant to an exemption
under the UK Prospectus Regulation or the EU Prospectus Regulation,
as appropriate, from the requirement to produce a prospectus. In
the United Kingdom, this Announcement is being directed solely at
persons in circumstances in which section 21(1) of Financial
Services and Markets Act 2000 (as amended) (the "FSMA") does not require the approval of
the relevant communication by an authorised person.
The Placing Shares have not been
approved or disapproved by the US Securities and Exchange
Commission, any state securities commission or other regulatory
authority in the United States, nor have any of the foregoing
authorities passed upon or endorsed the merits of the Placing or
the accuracy or adequacy of this Announcement. Any representation
to the contrary is a criminal offence in the United States. The
relevant clearances have not been, nor will they be, obtained from
the securities commission of any province or territory of Canada,
no prospectus has been lodged with, or registered by, the
Australian Securities and Investments Commission or the Japanese
Ministry of Finance; the relevant clearances have not been, and
will not be, obtained for the South Africa Reserve Bank or any
other applicable body in the Republic of South Africa in relation
to the Placing Shares and the Placing Shares have not been, nor
will they be, registered under or offered in compliance with the
securities laws of any state, province or territory of Australia,
Canada, Japan or the Republic of South Africa. Accordingly, the
Placing Shares may not (unless an exemption under the relevant
securities laws is applicable) be offered, sold, resold or
delivered, directly or indirectly, in or into Australia, Canada,
Japan, the Republic of South Africa or any other jurisdiction
outside the United Kingdom or the EEA.
Persons (including, without
limitation, nominees and trustees) who have a contractual right or
other legal obligation to forward a copy of this Announcement
should seek appropriate advice before taking any action.
Each Placee should consult with its own advisers as to legal,
regulatory, tax, business and related aspects of a subscription for
the Placing Shares. The price of shares and any income expected
from them may go down as well as up and Placees may not get back
the full amount invested upon disposal of the shares. Past
performance is no guide to future performance.
Placees, including any individuals,
funds or others on whose behalf a commitment to acquire Placing
Shares is given, will be deemed: (i) to have read and understood
this Announcement, including this Appendix, in its entirety; and
(ii) to be participating and making an offer for Placing Shares on
the terms and conditions contained herein and to be providing the
confirmations, agreements, representations, warranties,
acknowledgements and undertakings contained in this
Appendix.
Details of the Placing Agreement, the Placing Shares and the
Bookbuild
SCC is acting as nominated adviser
and SCS and Panmure Liberum are acting as Joint Bookrunners in
connection with the Placing and Admission.
Shore Capital and Panmure Liberum
have today entered into the Placing Agreement with the Company
under which, amongst other things, the Joint Bookrunners have
agreed, as agents for and on behalf of the Company, to use their
respective reasonable endeavours to procure subscribers for Placing
Shares, on the terms and subject to the conditions set out
herein.
The Joint Bookrunners will today
commence the Bookbuild to determine demand
for participation in the Placing by Placees immediately following
the publication of this Announcement. This Appendix gives details
of the terms and conditions of, and the mechanics of participation
in, the Placing. No commissions will be paid to Placees or by
Placees in respect of any Placing Shares. The Placing is not being
underwritten. The Placing Shares are not part of the Retail
Offer.
The Joint Bookrunners shall be
entitled to effect the Placing by such alternative method to the
Bookbuild as they may, in their discretion following consultation
with the Company, determine.
The Placing Shares will, when
issued, be subject to the articles of association of the Company,
be credited as fully paid up, rank in full for all dividends and
other distributions declared, made or paid on the Ordinary Shares
and otherwise rank pari
passu in all respects with, and be identical to, the
Existing Ordinary Shares.
Participation in, and principal terms of, the Bookbuild and
Placing
1 The Joint
Bookrunners are arranging the Placing as joint bookrunners and
agents of the Company for the purpose of procuring Placees at the
Issue Price for the Placing Shares.
2 Participation in
the Placing will only be available to persons who may lawfully be,
and are, invited to participate by the Joint Bookrunners. Each
Joint Bookrunner may severally (but is not obliged to) agree to be
a Placee in respect of all or some of the Placing Shares or may
nominate any member of its group to do so.
3 The Issue Price
will be a fixed price of 400 pence per Placing Share
and is payable to the Joint Bookrunners (as agents
for the Company) by all Placees whose bids are
successful.
4 The number of
Placing Shares to be issued at the Issue Price will be agreed by
the Joint Bookrunners in consultation with the Company following
completion of the Bookbuild and will be recorded in terms of
subscription entered into between the Joint Bookrunners and the
Company. The number of Placing Shares to be issued will be
announced by the Company on a Regulatory Information Service
following the completion of the Bookbuild.
5 Except as
required by law or regulation, no press release or other
announcement will be made by the Joint Bookrunners or the Company
using the name of any Placee (or its agent), in its capacity as
Placee (or agent), other than with such Placee's prior written
consent.
6 To bid in the
Bookbuild, Placees should communicate their bid by telephone or
email to their usual sales contact at the applicable Joint
Bookrunner. Each bid should state the number of Ordinary Shares
which the prospective Placee wishes to subscribe for at the Issue
Price. Bids may be scaled down by the Joint Bookrunners on the
basis referred to in paragraph 10 below. The Joint Bookrunners are arranging the Placing severally and
not jointly or jointly and severally as agents of the
Company.
7 A bid in the
Bookbuild will be made on the terms and subject to the conditions
in this Appendix and will be legally binding on
the Placee on behalf of which it is made and, except with the
relevant Joint Bookrunners' consent, will not be capable of
variation or revocation after the time at which it is submitted.
Following the relevant Joint Bookrunner's oral or written
confirmation of each Placee's allocation and commitment to acquire
Placing Shares, each Placee will also have an immediate, separate,
irrevocable and binding obligation, owed to the relevant Joint
Bookrunner (as agent for the Company), to pay to them (or as the
relevant Joint Bookrunner may direct) in cleared funds an amount
equal to the product of the Issue Price and the number of Placing
Shares that such Placee has agreed to subscribe for and the Company
has agreed to allot and issue to that Placee regardless of the
total number of Placing Shares (if any) subscribed for by any other
investor(s). Each prospective Placee's obligations will be owed to
the Company and the Joint Bookrunners.
8 The Bookbuild is
expected to close later today on 1 October 2024, but may close
later subject to the agreement of the Joint Bookrunners and the
Company. The Joint Bookrunners may, in agreement with the Company,
accept bids, either in whole or in part, that are received after
the Bookbuild has closed.
9 The Joint
Bookrunners are each acting exclusively for the Company and no one
else in connection with the matters referred to in this
Announcement and will not be responsible to anyone other than the
Company for protections afforded to their respective customers nor
for providing advice in relation to the matters described in this
Announcement or any matter, transaction or arrangement referred to
in it.
10 The Joint Bookrunners
may choose to accept bids, either in whole or in part, on the basis
of allocations determined in consultation with the Company and may
scale down any bids for this purpose on such basis as they may
determine or be directed. The Joint Bookrunners may also,
notwithstanding paragraphs 7 and 8 above, subject to the prior
consent of the Company:
(a) allocate
Placing Shares after the time of any initial allocation to any
person submitting a bid after that time; and
(b) allocate
Placing Shares after the Bookbuild has closed to any person
submitting a bid after that time.
11 The Company reserves
the right (upon agreement with the Joint Bookrunners) to reduce or
seek to increase the amount to be raised pursuant to the Placing at
its discretion.
12 Allocations of the
Placing Shares will be determined by the Joint Bookrunners in their
discretion after consultation with the Company in accordance with
the FCA Handbook Conduct of Business Sourcebook ("COBS"). Allocations will be confirmed
(either orally or in writing) by the relevant Joint Bookrunner and
a form of confirmation will be despatched as soon as possible
thereafter. The terms and conditions of this Appendix will be
deemed incorporated therein. The relevant Joint Bookrunner's
confirmation to such Placee constitutes an irrevocable legally
binding commitment upon such person (who will at that point become
a Placee), in favour of the Joint Bookrunners and the Company, to
acquire the number of Placing Shares allocated to it and to pay the
Issue Price in respect of such shares on the terms and conditions
set out in this Appendix and in accordance with the Company's
articles of association.
13 Irrespective of the
time at which a Placee's allocation(s) pursuant to the Placing
is/are confirmed, settlement for all Placing Shares to be acquired
pursuant to the Placing will be required to be made at the relevant
time, on the basis explained below under "Registration and
settlement".
14 All obligations of
the Joint Bookrunners under the Placing will be subject to
fulfilment or (where applicable) waiver of the conditions referred
to below under "Conditions of the
Placing" and to the Placing not being terminated on the
basis referred to below under "Right to terminate under the Placing
Agreement".
15 By participating in
the Bookbuild and the Placing, each Placee
will agree that its rights and obligations in respect of the
Placing will terminate only in the circumstances described below
under "Right to terminate under
the Placing Agreement" and will not be capable of rescission
or termination by the Placee.
16 To
the fullest extent permissible by law and applicable FCA rules and
regulations, neither:
(a)
the Joint Bookrunners;
(b) any of their respective affiliates, agents, directors,
officers or employees ("Representatives");
nor
(c)
to the extent not contained within (a) or (b), any
person connected with the Joint Bookrunners as defined in the FSMA
((b) and (c) being together "affiliates" and individually an
"affiliate" of the Joint
Bookrunners),
shall have any responsibility or
liability (including to the extent permissible by law, any
fiduciary duties) to Placees or to any other person whether acting
on behalf of a Placee or otherwise. In particular, none of the
Joint Bookrunners, the Company, nor any of their respective
Representatives shall have any responsibility or liability
(including to the extent permissible by law, any fiduciary duties)
in respect of the conduct of the Bookbuild and/or the Placing or of
such alternative method of effecting the Placing as the Joint
Bookrunners and the Company may determine. Each Placee acknowledges
and agrees that the Company is responsible for the allotment of the
Placing Shares to the Placees and the Joint Bookrunners shall have
no liability to the Placees for any failure by the Company to
fulfil those obligations.
17 The Placing Shares
will be issued subject to the terms and conditions of this Appendix
and each Placee's commitment to subscribe for Placing Shares on the
terms set out herein will continue notwithstanding any amendment
that may in future be made to the terms and conditions of the
Placing and Placees will have no right to be consulted or require
that their consent be obtained with respect to the Company's or the
Joint Bookrunners' conduct of the Placing.
18 The times and dates
in this Announcement may be subject to amendment. The Joint
Bookrunners shall notify the Placees and any person acting on
behalf of the Placees of any such changes.
Conditions of the Placing
The Joint Bookrunner's obligations
under the Placing Agreement in respect of the Placing Shares are
conditional on, inter
alia:
· the
Acquisition Agreement having been entered into and duly executed by
the parties thereto;
· the
Facilities Agreement having been entered into and duly executed by
the parties thereto;
· the
Company allotting, subject only to Admission, the Placing Shares in
accordance with the Placing Agreement;
· the
Placing Agreement having become unconditional in respect of the
Placing (save for any condition as to Admission having taken place)
and not having been terminated in accordance with its terms before
Admission; and
· Admission taking place no later than 8.00 a.m. 21 October 2024
or such other time and/or date as may be agreed between the Company
and the Joint Bookrunners, not being later than 8.00 a.m. on 28
October 2024 (the "Final
Date").
If (i) any of the conditions
contained in the Placing Agreement in relation to the Placing
Shares is not fulfilled or, if permitted, waived by the Joint
Bookrunners in accordance with the Placing Agreement by the
respective time or date where specified (or such later time or date
as the Company and each of the Joint Bookrunners may agree not
being later than the Final Date), or (ii) the Placing Agreement is
terminated in accordance with its terms, the Placing will lapse and
the Placees' rights and obligations hereunder in relation to the
Placing Shares shall cease and terminate at such
time. In such instance,
each Placee agrees that no claim can be made by or on behalf of the
Placee (or any person on whose behalf the Placee is acting) in
respect thereof.
The Joint Bookrunners may, in their
absolute discretion, waive, or extend the period (up to the Final
Date) for compliance by the Company with the whole or any part of
any of the Company's obligations in relation to the conditions in
the Placing Agreement, save that the conditions relating to the
Acquisition Agreement, the Facilities Agreement and Admission
taking place may not be waived. The period for compliance with such
conditions may not be extended beyond the Final Date. Any such
extension or waiver will not affect Placees' commitments as set out
in this Appendix.
Neither the Joint Bookrunners nor
any of their respective affiliates nor the Company shall have any
liability to any Placee (or to any other person whether acting on
behalf of a Placee or otherwise) in respect of any decision they
may make as to whether or not to waive or to extend the time and/or
date for the satisfaction of any condition to the Placing nor for
any decision they may make as to the satisfaction of any condition
or in respect of the Placing generally and by participating in the
Placing each Placee agrees that any such decision is within the
absolute discretion of the Joint Bookrunners.
Right to terminate under the Placing
Agreement
Either or both of the Joint
Bookrunners may, in its or their absolute discretion, at any time
before Admission, terminate the Placing Agreement by giving notice
to the Company if, inter
alia:
(a) any of the warranties contained in the Placing Agreement given
by the Company to the Joint Bookrunners is untrue or inaccurate or
misleading; or
(b) any party to the Acquisition Agreement terminates, or has
given notice to terminate the Acquisition Agreement; or
(c) in the opinion of either or both of the Joint Bookrunners
(acting in good faith), there has been a development or event (or
any development or event involving a prospective change of which
the Company is, or might reasonably be expected to be, aware) which
will or is likely to have a material adverse effect on or affecting
the operations, the condition (financial, operational, legal or
otherwise), or in the earnings, results of operations, business
affairs, management, properties, assets, rights, operations,
solvency, credit rating, prospects or funding position of the
Company's group (taken as a whole) respectively whether or not
foreseeable and whether or not arising in the ordinary course of
business; or
(d) it shall come to the knowledge of the Joint Bookrunners that
there has been any breach by the Company of any of its material
obligations under the Retail Offer and such breach, in the opinion
of the Joint Bookrunners (acting in good faith) is material in the
context of the Placing and Admission; or
(e) the Retail Offer is terminated and such termination, in the
opinion of the Joint Bookrunners (acting in good faith) is material
in the context of the Placing and Admission; or
(f)
in the opinion of the Joint Bookrunners (acting in
good faith) there has been any material adverse change in the
financial markets in the United States, the United Kingdom or the
international financial markets, any outbreak or material
escalation of hostilities, war, act of terrorism, declaration of
emergency or martial law or other calamity or crisis or event or
any change or development involving a prospective change in
national or international political, financial, economic, monetary
or market conditions or currency exchange rates or controls, in
each case, in any jurisdiction a suspension or material limitation
by the London Stock Exchange on any exchange or over-the-counter
market, or if trading generally on the London Stock Exchange, New
York Stock Exchange or a major financial market has been suspended
or materially limited; or; or
(g) any matter or circumstance arises as a result of which it is
reasonable to expect that any of the conditions of the Placing
Agreement will not be satisfied at the required time(s) (if any)
and continue not to be satisfied as at Admission.
If one Joint Bookrunner (the
"Withdrawing Joint Bookrunner")
but not both Joint Bookrunners serves notice to terminate the
Placing Agreement, the other Joint Bookrunner (the
"Continuing Joint Bookrunner")
may, in its absolute discretion and without obligation, within 24
hours thereafter, elect, by giving notice to the Company, to allow
the Placing to proceed on the basis that the Continuing Joint
Bookrunner shall assume any and all obligations of the Withdrawing
Joint Bookrunner save (i) where the Withdrawing Joint Bookrunner is
the Company's nominated adviser, as nominated adviser to the
Company and (ii) as regards any breach of the terms of the Placing
Agreement by the Withdrawing Joint Bookrunner prior to the date of
such termination, which remain to be performed under the Placing
Agreement. If the Continuing Joint Bookrunner fails to make that
election to the Company within such 24 hour period then the Placing
Agreement will terminate.
The rights and obligations of the
Placees shall terminate only in the circumstances described in
these terms and conditions and in the Placing Agreement and will
not be subject to termination by any Placee or any prospective
Placee at any time or in any circumstances and the Placees'
participation will not be capable of rescission or termination by
it after oral confirmation by the Joint Bookrunners of the
allocation and commitments following the close of the Bookbuild. By
participating in the Placing, Placees agree that the exercise by
either or both of the Joint Bookrunners of any right of termination
or other discretion under the Placing Agreement shall be within the
absolute discretion of the Joint Bookrunners, that they need not
make any reference to Placees and that none of the Company, the
Joint Bookrunners nor any of their respective Representatives shall
have any liability to Placees (or to any other person whether
acting on behalf of a Placee or otherwise) whatsoever in connection
with any such exercise or decision not to
exercise.
Placees agree that they will have no
rights against the Joint Bookrunners, the Company or any of their
respective directors or employees under the Placing Agreement
pursuant to the Contracts (Rights of Third Parties) Act 1999 (as
amended).
By participating in the Placing,
each Placee agrees that its rights and obligations terminate only
in the circumstances described above and under the "Conditions of the Placing" section
above and will not be capable of rescission or termination by it
after the issue by the Joint Bookrunners of a contract note,
electronic trade confirmation or other (oral or written)
confirmation confirming each Placee's allocation and commitment in
the Placing.
Restriction on further issue of shares and certain other
matters
The Company has undertaken to the
Nominated Adviser and the Joint Bookrunners that it will not, and
will procure that neither it nor any member of the Group will,
between the date of the Placing Agreement and 180 days after
Admission issue, offer, lend, mortgage, assign,
charge, pledge, sell, contract to sell or issue, grant any option,
right or warrant to purchase, lend or otherwise transfer or dispose
of or announce any offering or issuance of any Ordinary Shares or
any interest in Ordinary Shares or any securities convertible into
or exchangeable for or substantially similar to Ordinary Shares or
any interest in Ordinary Shares.
The Company has also undertaken to
the Nominated Adviser and the Joint Bookrunners that it will not,
and will procure that neither it nor any member of the Group will,
between the date of the Placing Agreement and 120 days after
Admission, inter alia, enter into any agreement, commitment or
arrangement which is or may be material in the context of the
business or affairs of the Group or which could adversely affect
the Placing without having first obtained the prior written consent
of each of the Joint Bookrunners.
No
prospectus
The Placing Shares are being offered
to a limited number of specifically invited persons only and will
not be offered in such a way as to require any prospectus or other
offering document to be published. No offering document or
prospectus has been or will be submitted to be approved by the FCA
or submitted to the London Stock Exchange in relation to the
Placing or the Placing Shares.
Placees' commitments will be made
solely on the basis of (i) publicly available information announced
through a Regulatory Information Service by or on behalf of the
Company on or prior to the date of this Announcement, (ii) the
information contained in this Announcement and (iii) business and
financial information published in accordance with the rules and
practices under the AIM Rules and UK MAR (together, the
"Publicly Available
Information") and subject to the further terms set
forth in the form of confirmation.
Each Placee, by participating in the
Placing, agrees that the content of this Announcement is
exclusively the responsibility of the Company and confirms that it
has neither received nor relied on any other information (other
than Publicly Available Information), representation, warranty or
statement made by or on behalf of the Company, the Nominated
Adviser or the Joint Bookrunners or any other person and none of
the Company, the Nominated Adviser, the Joint Bookrunners nor any
other person acting on such person's behalf nor any of their
respective Representatives has or shall have any liability for any
Placee's decision to participate in the Placing based on any other
information, representation, warranty or statement which the
Placees may have obtained or received. Each Placee acknowledges and
agrees that it has relied on its own investigation of the business,
financial or other position of the Company in accepting a
participation in the Placing. No Placee should consider any
information in this Announcement to be legal, tax or business
advice. Nothing in this paragraph shall exclude the liability of
any person for fraudulent misrepresentation by that
person.
Application for admission to trading
Application will be made to the
London Stock Exchange for admission of the Placing Shares to
trading on AIM. It is expected that Admission will take place
at 8.00 a.m. on 21 October 2024 specified (or such later time or
date as the Company and each of the Joint Bookrunners may agree not
being later than the Final Date) and that dealings in the Placing
Shares on AIM will commence at the same time.
Registration and settlement
Settlement of transactions in the
Placing Shares following Admission will take place within the CREST
system, subject to certain exceptions. Settlement within CREST is
expected to occur on 21 October 2024 (the "Settlement Date"). Settlement will take
place on a delivery versus payment basis. However, the Joint
Bookrunners and the Company reserve the right to require settlement
for, and delivery of, the Placing Shares (or any part thereof) to
Placees by such other means that they deem necessary if delivery or
settlement is not possible or practicable within CREST within the
timetable set out in this Announcement or would not be consistent
with the regulatory requirements in the Placee's
jurisdiction.
Each Placee allocated Placing Shares
in the Placing will be sent a form of confirmation in accordance
with the standing arrangements in place with the relevant Joint
Bookrunner stating the number of Placing Shares allocated to it at
the Issue Price, the aggregate amount owed by such Placee to the
relevant Joint Bookrunner and settlement instructions. Each Placee
agrees that it will do all things necessary to ensure that delivery
and payment is completed in accordance with the standing CREST or
certificated settlement instructions in respect of the Placing
Shares that it has in place with the relevant Joint
Bookrunner.
Interest is chargeable daily on
payments not received from Placees on the due date in accordance
with the arrangements set out above, in respect of either CREST or
certificated deliveries, at the rate of two percentage points above
the prevailing base rate of Barclays Bank as determined by the
Joint Bookrunners.
Subject to the conditions set out
above, payment in respect of the Placees' allocations is due as set
out below. Each Placee should provide its settlement details in
order to enable instructions to be successfully matched in
CREST.
The relevant settlement details for
the Placing Shares are as follows:
CREST Participant ID of
SCS:
|
601
|
CREST Participant ID of Panmure
Liberum:
|
7BUAG
|
Expected trade time and
date:
|
8.00 a.m.
on 17 October 2024
|
Settlement date:
|
21 October
2024
|
ISIN code for the Placing
Shares:
|
GB0005991111
|
Each Placee is deemed to agree that,
if it does not comply with these obligations, the Joint Bookrunners
may sell any or all of the Placing Shares allocated to that Placee
on such Placee's behalf and retain from the proceeds, for the
relevant Joint Bookrunners' account and benefit, an amount equal to
the aggregate amount owed by the Placee plus any interest due. The
relevant Placee will, however, remain liable for any shortfall
below the aggregate amount owed by it and may be required to bear
any stamp duty or stamp duty reserve tax (together with any
interest or penalties) or other similar taxes imposed in any
jurisdiction which may arise upon the sale of such Placing Shares
on such Placee's behalf. By communicating a
bid for Placing Shares, such Placee confers on the Joint
Bookrunners all such authorities and powers necessary to carry out
such sale and agrees to ratify and confirm all actions which the
relevant Joint Bookrunner lawfully takes in pursuance of such
sale.
If Placing Shares are to be
delivered to a custodian or settlement agent, Placees should ensure
that the form of confirmation is copied and delivered immediately
to the relevant person within that organisation.
Insofar as Placing Shares are
registered in a Placee's name or that of its nominee or in the name
of any person for whom a Placee is contracting as agent or that of
a nominee for such person, such Placing Shares should, subject as
provided below, be so registered free from any liability to United
Kingdom stamp duty or stamp duty reserve tax. If there are any
circumstances in which any United Kingdom stamp duty or stamp duty
reserve tax or other similar taxes or duties (including any
interest and penalties relating thereto) is payable in respect of
the allocation, allotment, issue, sale, transfer or delivery of the
Placing Shares (or, for the avoidance of
doubt, if any stamp duty or stamp duty reserve tax is payable in
connection with any subsequent transfer of or agreement to transfer
Placing Shares), none of the Nominated Adviser, the Joint
Bookrunners nor the Company shall be responsible for payment
thereof.
Representations, warranties, undertakings and further
terms
By submitting a bid in the
Bookbuild, each Placee (and any person acting on such Placee's
behalf) irrevocably confirms, represents, warrants, acknowledges,
agrees and undertakes (as the case may be) with the Company and the
Joint Bookrunners (in their
capacity as bookrunners and placing agents of the Company in
respect of the Placing), that (save where the Joint Bookrunners
expressly agree in writing to the contrary):
1 it has read and
understood this Announcement in its entirety and that its
acquisition of the Placing Shares is subject to and based upon all
the terms, conditions, representations, warranties, indemnities,
acknowledgements, agreements and undertakings and other information
contained herein and it has not relied on,
and will not rely on, any information given or any representations,
warranties or statements made at any time by any person in
connection with Admission, the Placing, the Company, the Placing
Shares or otherwise, other than the information contained in this
Announcement and the Publicly Available Information and undertakes
not to redistribute or duplicate this Announcement;
2 its obligations
are irrevocable and legally binding and shall not be capable of
rescission or termination by it in any circumstances;
3 no offering
document, admission document or prospectus has been or will be
prepared in connection with the Placing (nor is one required under
the UK Prospectus Regulation or other applicable law) and
represents and warrants that it has not received and will not
receive a prospectus, admission document or other offering document
in connection with the Placing or the Placing Shares;
4 the Placing does
not constitute a recommendation or financial product advice and the
Nominated Adviser and the Joint Bookrunners has had regard to its
particular objectives, financial situation or needs;
5 none of the
Nominated Adviser, the Joint Bookrunners, the Company nor any of
their respective Representatives has provided, nor will provide, it
with any material regarding the Placing Shares or the Company other
than the Circular (when published) and this Announcement; nor has
it requested any of the Nominated Adviser, the Joint Bookrunners,
the Company, any of their respective affiliates or any person
acting on behalf of any of them to provide it with any such
information;
6 the Ordinary
Shares are admitted to trading on AIM, and that the Company is
therefore required to publish certain business and financial
information in accordance with the rules and practices under the
AIM Rules and UK MAR, which includes a description of the Company's
business and the Company's financial information, including balance
sheets and income statements, and that it is able to obtain or
access such information, or comparable information concerning other
publicly traded companies, in each case without undue
difficulty;
7 the content of
the Circular (when published), this Announcement and the Publicly
Available Information is exclusively the responsibility of the
Company and that none of the Nominated Adviser, the Joint
Bookrunners, any persons acting on their behalf nor any of their
respective affiliates, has or shall have any liability for any
information, representation, warranty or statement relating to the
Company contained in, or omission from, the Circular (when
published), this Announcement or any Publicly Available
Information, nor will they be liable for any Placee's decision to
participate in the Placing based on any information,
representation, warranty or statement contained in the Circular
(when published), this Announcement, the Publicly Available
Information or otherwise. Nothing in this Appendix shall exclude
any liability of any person for fraudulent
misrepresentation;
8 the content of
this Announcement is exclusively the responsibility of the Company
and the Directors and neither the Nominated Adviser, the Joint
Bookrunners nor any person acting on behalf of either of them or
any of their respective Representatives has or shall have any
liability for any Publicly Available Information or any
representation or statement relating to the Company;
9 it, and any
prospective beneficial owner for whose account or benefit it is
purchasing the Placing Shares, is and, at the time the Placing
Shares are subscribed for, will be located outside the United
States and is acquiring the Placing Shares in an "offshore
transaction" as defined in, and in accordance with, Regulation S
under the Securities Act;
10 it has not been
offered to purchase or subscribe for Placing Shares by means of
any "directed selling efforts" as defined in
Regulation S of the Securities Act;
11 it understands that
the Placing Shares:
(a) have not been and will not
be registered or otherwise qualified for offer and sale and that a
prospectus will not be cleared or approved in respect of any of the
Placing Shares under the securities laws of the United States,
Australia, Canada, Japan, the Republic of South Africa, or any
state, province, territory or jurisdiction thereof;
(b) may not be offered, sold,
or delivered or transferred, directly or indirectly, in or into the
above jurisdictions or any jurisdiction (subject to certain
exceptions) in which it would be unlawful to do so and no action
has been or will be taken by any of the Company, the Nominated
Adviser, the Joint Bookrunners or any person acting on behalf of
the Company or, the Nominated Adviser or the Joint Bookrunners that
would, or is intended to, permit a public offer of the Placing
Shares in the United States, Australia, Canada, Japan, the Republic
of South Africa or any country or jurisdiction, or any state,
province, territory or jurisdiction thereof, where any such action
for that purpose is required;
12 it is not, and any
person who it is acting on behalf of is not, and at the time the
Placing Shares are subscribed for, neither it nor
the beneficial owner of the Placing Shares will be, a resident of,
nor have an address in, Australia, Japan, the Republic of South
Africa or any province or territory of Canada;
13 it will not offer,
sell, transfer, pledge or otherwise dispose of any Placing Shares
except:
(a) in an offshore transaction
in accordance with Rules 903 or 904 of Regulation S under the
Securities Act; or
(b) pursuant to another
exemption from registration under the Securities Act, if
available,
and in each case in accordance with
all applicable securities laws of the states of the United States
and other jurisdictions;
14 it understands that
the Placing Shares have not been, and will not be, registered under
the Securities Act and may not be offered, sold or resold in or
into or from the United States or to, or for the account or benefit
of, US Persons (as defined in Regulation S) except pursuant to an
effective registration under the Securities Act, or pursuant to an
exemption from the registration requirements of the Securities Act
and in accordance with applicable state securities laws;
15 it will not
distribute, forward, transfer or otherwise transmit this
Announcement or any part of it, or any other
presentational or other materials concerning the Placing in or into
or from the United States, Australia, Canada, Japan, the Republic
of South Africa (including electronic copies thereof) to any
person, and it has not distributed, forwarded, transferred or
otherwise transmitted any such materials to any such
person;
16 it understands that
there may be certain consequences under United States and other tax
laws resulting from an investment in the Placing and it has made
such investigation and has consulted its own independent advisers
or otherwise has satisfied itself concerning, without limitation,
the effects of United States federal, state and local income tax
laws and foreign tax laws generally;
17 it:
(a) has such knowledge and
experience in financial and business matters to be capable of
evaluating the merits and risks of subscribing for or purchasing
the Placing Shares;
(b) will not look to the
Nominated Adviser or the Joint Bookrunners for all or part of any
loss it may suffer as a result of any such subscription or
purchase;
(c) is experienced in
investing in securities of this nature in this sector and is aware
that it may be required to bear, and is able to bear, the economic
risk of an investment in the Placing Shares;
(d) is able to sustain a
complete loss of an investment in the Placing Shares;
and
(e) has no need for liquidity
with respect to its investment in the Placing Shares;
18 the
issue to it, or the person specified by it, for registration as
holder, of the Placing Shares will not give rise to a stamp duty or
stamp duty reserve tax liability under (or at a rate determined
under) any of sections 67, 70, 93 or 96 of the Finance Act 1986
(depositary receipts and clearance services) and that the Placing
Shares are not being acquired in connection with arrangements to
issue depositary receipts or to issue or transfer Placing Shares
into a clearance service;
19 it has complied with
its obligations in connection with money laundering and terrorist
financing under the Proceeds of Crime Act 2002 (as amended), the
Terrorism Act 2000 (as amended), the Terrorism Act 2006, the Money
Laundering, Terrorist Financing and Transfer of Funds (Information
on the Payer) Regulations 2017 (as amended) and all related or
similar rules, regulations or guidelines, issued, administered or
enforced by any government agency having jurisdiction in respect
thereof and the Money Laundering Sourcebook of the FCA (together,
the "Money Laundering
Regulations") and, if making payment on behalf of a third
party, that satisfactory evidence has been obtained and recorded by
it to verify the identity of the third party as required by the
Money Laundering Regulations;
20 it is not:
(a) an entity or an individual
with whom transactions are prohibited under the US Foreign Corrupt
Practices Act of 1977 or is the subject of any economic sanction
programmes administered by, or regulations promulgated by, the
Office of Foreign Assets Control of the U.S. Department of the
Treasury;
(b) named on the Consolidated
List of Financial Sanctions Targets maintained by HM Treasury of
the United Kingdom; or
(c) subject to financial
sanctions imposed pursuant to a regulation of the European Union or
a regulation adopted by the United Nations or other applicable
law,
(together with the Money Laundering
Regulations, the "Regulations") and if making payment on
behalf of a third party, that satisfactory evidence has been
obtained and recorded by it to verify the identity of the third
party as required by the Regulations and has obtained all
governmental and other consents (if any) which may be required for
the purpose of, or as a consequence of, such purchase, and it will
provide promptly to the Joint Bookrunners such evidence, if any, as
to the identity or location or legal status of any person which
they may request from it in connection with the Placing (for the
purpose of complying with the Regulations or ascertaining the
nationality of any person or the jurisdiction(s) to which any
person is subject or otherwise) in the form and manner requested by
the Joint Bookrunners on the basis that any failure by it to do so
may result in the number of Placing Shares that are to be acquired
by it or at its direction pursuant to the Placing being reduced to
such number, or to nil, as the Joint Bookrunners may decide at
their sole discretion;
21 in order to ensure
compliance with the Regulations, the Joint Bookrunners (for
themselves severally and as agent on behalf of the Company), or the
Company's registrars may, in their absolute discretion, require
verification of its identity, location or legal status. Pending the
provision to the Joint Bookrunners or the Company's registrars, as
applicable, of evidence of identity, location or legal status,
definitive certificates in respect of the Placing Shares may be
retained at the Joint Bookrunners' absolute discretion or, where
appropriate, delivery of the Placing Shares to it in uncertificated
form may be delayed in either of the Joint
Bookrunner's or the Company's registrars', as the case may be,
absolute discretion. If within a reasonable time after a request
for verification of identity, location or legal status, the Joint
Bookrunners (for themselves severally and as agent on behalf of the
Company), or the Company's registrars have not received evidence
satisfactory to them, either Joint Bookrunner and/or the Company may, at its absolute discretion, terminate
its commitment in respect of the Placing, in which event the monies
payable on the conditional allocation of Placing Shares allotment
will, if already paid, be returned without interest to the account
of the drawee's bank from which they were originally
debited;
22 it irrevocably
appoints any duly authorised officer of each Joint Bookrunner as
its agent for the purpose of executing and delivering to the
Company and/or its registrars any documents on its behalf necessary
to enable it to be registered as the holder of any of the Placing
Shares for which it agrees to acquire upon the terms of this
Announcement;
23 its participation in
the Placing would not give rise to an offer being required to be
made by it, or any person with whom it is acting in concert,
pursuant to Rule 9 of the City Code on Takeovers and
Mergers;
24 it is acting as
principal only in respect of the Placing or, if it is acting for
any other person: (i) it is duly authorised to do so and has full
power to make the acknowledgements, warranties, representations,
confirmations, undertakings, and agreements herein on behalf of
each such person; and (ii) it is and will remain liable to the
Company and/or Joint Bookrunners for the performance of all its
obligations as a Placee in respect of the Placing (regardless of
the fact that it is acting for another person);
25 if it is a financial
intermediary, as that term is used in Article 2(d) of the EU
Prospectus Regulation or Article 5(1) the UK Prospectus Regulation,
as applicable, it understands the resale and transfer restrictions
set out in this Appendix and that any Placing Shares acquired by it
in the Placing will not be acquired on a non-discretionary basis on
behalf of, nor will they be acquired with a view to their offer or
resale to, persons in circumstances which may give rise to an offer
of securities to the public other than an offer or resale in a
member state of the EEA to EEA Qualified Investors or in the United
Kingdom to Relevant Persons, or in circumstances in which the prior
consent of the Joint Bookrunners has been given to each such
proposed offer or resale;
26 it has not offered or
sold and will not offer or sell any Placing Shares to persons in
the EEA, except to Qualified Investors as defined in Article 2(e)
of the EU Prospectus Regulation or otherwise in circumstances which
have not resulted and which will not result in an offer to the
public in any member state in the EEA within the meaning of Article
2(d) of the EU Prospectus Regulation;
27 it has not offered or
sold and will not offer or sell any Placing Shares to persons in
the United Kingdom, except to Qualified Investors as defined in
Article 2(e) of the UK Prospectus Regulation or otherwise in
circumstances which have not resulted and which will not result in
an offer to the public in the United Kingdom within the meaning of
Article 2(d) of the UK Prospectus Regulation;
28 it has not offered or
sold and will not offer or sell any Placing Shares to persons in
the United Kingdom or a member state of the EEA prior to the expiry
of a period of six months from Admission except to persons whose
ordinary activities involve them in acquiring, holding, managing or
disposing of investments (as principal or agent) for the purposes
of their business or otherwise in circumstances which have not
resulted and which will not result in an offer to the public in the
United Kingdom within the meaning of section 85(1) of the FSMA or
within the meaning of the UK Prospectus Regulation, or an offer to
the public in any member state of the EEA within the meaning of the
EU Prospectus Regulation;
29 it has only
communicated or caused to be communicated and will only communicate
or cause to be communicated any invitation or inducement to engage
in investment activity (within the meaning of section 21 of the
FSMA) relating to the Placing Shares in circumstances in which
section 21(1) of the FSMA does not require approval of the
communication by an authorised person and it acknowledges and
agrees that this Announcement has not been approved by either Joint
Bookrunner in its capacity as an authorised person under section 21
of the FSMA and it may not therefore be subject to the controls
which would apply if it was made or approved as financial promotion
by an authorised person;
30 it has complied and
will comply with all applicable laws with respect to anything done
by it or on its behalf in relation to the Placing Shares (including
all applicable provisions of the FSMA, the Criminal Justice Act
1993 and UK MAR) with respect to anything done by it in relation to
the Placing Shares in, from or otherwise involving the United
Kingdom;
31 unless otherwise
specifically agreed with the Nominated Adviser and the Joint
Bookrunners in writing, in the case of a Relevant Person in the
United Kingdom who acquires any Placing Shares pursuant to the
Placing, it is a Qualified Investor within the meaning of Article
2(e) of the UK Prospectus Regulation and in the case of a Relevant
Person in a member state of the EEA who acquires any Placing Shares
pursuant to the Placing, that it is a Qualified Investor within the
meaning of Article 2(e) of the EU Prospectus Regulation;
32 if in the United
Kingdom, that it is a person (i) having professional experience in
matters relating to investments who falls within the definition of
"investment professionals" in Article 19(5) of the Order or (ii)
who falls within Article 49(2)(a) to (d) ("High Net Worth
Companies, Unincorporated Associations, etc") of the Order, or
(iii) to whom this Announcement may otherwise lawfully be
communicated;
33 if in the United
Kingdom, unless otherwise agreed by the Joint Bookrunners, it is a
"professional client" or an "eligible counterparty" within the
meaning of Chapter 3 of COBS and it is acquiring Placing Shares for
investment only and not with a view to resale or
distribution;
34 either Joint
Bookrunner may choose to invoke the CASS Delivery Versus Payment
exemption (under CASS 7.11.14R within the FCA Handbook Client
Assets Sourcebook) with regard to settlement of funds, in
connection with the Placing, should it see fit;
35 neither it nor, as
the case may be, its clients expect the Joint Bookrunners to have
any duties or responsibilities to such persons similar or
comparable to the duties of "best execution" and "suitability"
imposed by COBS, and that the Joint Bookrunners are not acting for
it or its clients, and that the Joint Bookrunners will not be
responsible for providing the protections afforded to clients of
the Joint Bookrunners or for providing advice in respect of the
transactions described in this Announcement;
36 it and any person
acting on its behalf is entitled to acquire the Placing Shares
under the laws of all relevant jurisdictions and
that it has fully observed such laws and obtained all such
governmental and other guarantees, permits, authorisations,
approvals and consents which may be required thereunder and
complied with all necessary formalities to enable it to commit to
this participation in the Placing and to perform its obligations in
relation thereto (including, without limitation, in the case of any
person on whose behalf it is acting, all necessary consents and
authorities to agree to the terms set out or referred to in this
Appendix) and will honour such obligations and that it has not
taken any action or omitted to take any action which will or may
result in the Nominated Adviser, the Joint Bookrunners, the Company
or any of their respective directors, officers, agents, employees
or advisers acting in breach of the legal or regulatory
requirements of any jurisdiction in connection with the
Placing;
37 it (and any person
acting on its behalf) will make payment in respect of the Placing
Shares allocated to it in accordance with this
Appendix on the due time and date set out herein, failing which the
relevant Placing Shares may be placed with other acquirers or sold
as the Joint Bookrunners may each in their sole discretion
determine and without liability to such Placee, who will remain
liable for any amount by which the net proceeds of such sale fall
short of the product of the Issue Price and the number of Placing
Shares allocated to it and may be required to bear any stamp duty,
stamp duty reserve tax or other similar taxes (together with any
interest or penalties) which may arise upon such placing or sale of
such Placee's Placing Shares;
38 none of the Nominated Adviser, the Joint Bookrunners, nor any
of their respective Representatives nor any person
acting on behalf of any of them is making any recommendations to it
or advising it regarding the suitability of any transactions it may
enter into in connection with the Placing and that its
participation in the Placing is on the basis that it is not and
will not be a client of either the
Nominated Adviser or the Joint Bookrunners in connection with its participation in the Placing and that
neither the Nominated Adviser nor the Joint
Bookrunners have any duty nor
responsibility to it for providing the protections afforded to its
clients or customers or for providing advice in relation to the
Placing nor in respect of any representations, warranties,
undertakings or indemnities contained in the Placing Agreement nor
for the exercise or performance of any of its rights and
obligations thereunder including any rights to waive or vary any
conditions or exercise any termination right;
39 the person whom it
specifies for registration as holder of the Placing Shares will be
(i) itself or (ii) its nominee, as the case may be. None of
the Nominated Adviser, the Joint
Bookrunners nor the Company will be responsible for any
liability to stamp duty or stamp duty reserve tax or other similar
taxes resulting from a failure to observe this requirement
("Indemnified Taxes"); each
Placee and any person acting on behalf of such Placee agrees to
indemnify the Company, the Nominated Adviser and
the Joint Bookrunners, on an after-tax basis in respect of
any Indemnified Taxes;
40 indemnify on an after
tax basis and hold the Company, the Nominated
Adviser, the Joint Bookrunners and each of their respective
Representatives harmless from any and all costs, claims,
liabilities and expenses (including legal fees and expenses)
arising out of or in connection with any breach of its
representations, warranties, acknowledgements, agreements and
undertakings in this Appendix or incurred by the Joint Bookrunners,
the Company or each of their respective Representatives arising
from the performance of the Placee's obligations as set out in this
Announcement, and further agrees that the provisions of this
Appendix shall survive after completion of the Placing;
41 except as set out in
paragraph 42 below, it has neither received nor relied on any
'inside information' (for the purposes of UK MAR and section 56 of
the Criminal Justice Act 1993) concerning the Company prior to or
in connection with accepting the invitation to participate in the
Placing and is not purchasing Placing Shares on the basis of
material non-public information;
42 if it has received
any 'inside information' (for the purposes of UK MAR and section 56
of the Criminal Justice Act 1993 or other
applicable law) in relation to the Company and its securities in
advance of the Placing, it has received such information within the
market soundings regime provided for in Article 11 of UK MAR and
associated delegated regulations and it has not: (i) dealt (or
attempted to deal) in the securities of the Company; (ii)
encouraged, recommended or induced another person to deal in the
securities of the Company; or (iii) unlawfully disclosed inside
information to any person, prior to the information being made
publicly available;
43 if it is a pension
fund or investment company, its purchase of Placing Shares is in
full compliance with applicable laws and regulations;
44 the Company,
the Nominated Adviser, the Joint
Bookrunners and their respective affiliates and others will
rely upon the truth and accuracy of the foregoing representations,
warranties, acknowledgements, agreements, and undertakings which
are given to the Nominated Adviser and the Joint
Bookrunners for themselves and on behalf of the Company and
are irrevocable and it irrevocably authorises the Company,
the Nominated Adviser and the Joint
Bookrunners to produce this Announcement, pursuant to, in
connection with, or as may be required by, any applicable law or
regulation, administrative or legal proceeding or official inquiry
with respect to the matters set forth herein;
45 none of the Company,
the Nominated Adviser or the Joint
Bookrunners owes any fiduciary or other duties to any Placee
in respect of any acknowledgments, confirmations, undertakings,
representations, warranties or indemnities in the Placing
Agreement;
46 its commitment to
take up Placing Shares on the terms set out in this Announcement
(including this Appendix) will continue notwithstanding any
amendment that may or in the future be made to the terms and
conditions of the Placing and that Placees will have no right to be
consulted or require that their consent be obtained with respect to
the Company, the Nominated Adviser's or the Joint
Bookrunners' conduct of the Placing;
47 its allocation (if
any) of Placing Shares will represent a maximum number of Placing
Shares which it will be entitled, and required, to subscribe for,
and that the Nominated Adviser, the Joint
Bookrunners or the Company may call upon it to subscribe for
a lower number of Placing Shares (if any), but in no event in
aggregate more than the aforementioned maximum;
48 it has the funds
available to pay for the Placing Shares for which it has agreed to
acquire and acknowledges and agrees that it will pay the total
subscription amount in accordance with the terms of this
Announcement on the due time and date set out herein, failing which
the relevant Placing Shares may be placed with other Placees or
sold at such price as the Joint Bookrunners determine;
49 time is of essence as
regards its obligations under this Appendix;
50 it may be asked to
disclose in writing or orally to the Joint Bookrunners: (i) if he
or she is an individual, his or her nationality; or (ii) if he or
she is a discretionary fund manager, the jurisdiction in which the
funds are managed or owned;
51 information provided
by it to the Company and the Registrar will be stored on the
Company's and/or the Registrars' computer
system(s), and acknowledges and agrees that for the purposes of the
General Data Protection Regulation (EU) 2016/679 and other relevant
data protection legislation which may be applicable (the
"Data Protection Law"), the
Company and the Registrars are required to specify the purposes for
which they will hold personal data; and that it has obtained the
consent of any data subjects to the Registrars and the Company and
their respective associates holding and using their personal data
for the Purposes (as defined below). For the purposes of this
Announcement, "data subject", "personal data" and "sensitive
personal data" shall have the meanings attributed to them in the
Data Protection Law. The Company and the Registrars will only use
such information for the purposes set out below (collectively, the
"Purposes"), being
to:
(a) process its personal data
(including sensitive personal data) as required by or in connection
with its holding of Ordinary Shares, including processing personal
data in connection with credit and money laundering checks on
it;
(b) communicate with it as
necessary in connection with its affairs and generally in
connection with its holding of Ordinary Shares;
(c) provide personal data to
such third parties as the Company or the Registrars may consider
necessary in connection with its affairs and generally in
connection with its holding of Ordinary Shares or as the Data
Protection Law may require, including to third parties outside the
United Kingdom or the EEA;
(d) without limitation,
provide such personal data to the Company or the Nominated Adviser
or the Joint Bookrunners for processing, notwithstanding that any
such party may be outside the United Kingdom or the EEA States;
and
(e) process its personal data
for the Company's or Registrars' internal administration;
and
52 these terms and
conditions and any agreements entered into by it pursuant to the
terms and conditions set out in this Appendix, and all
non-contractual or other obligations arising out of or in
connection with them, shall be governed by and construed in
accordance with the laws of England and Wales and it submits (on
behalf of itself and on behalf of any person on whose behalf it is
acting) to the exclusive jurisdiction of the English courts as
regards any claim, dispute or matter arising out of any such
contract (including any dispute regarding the existence, validity
or termination of such contract or relating to any non-contractual
or other obligation arising out of or in connection with such
contract), except that enforcement proceedings in respect of the
obligation to make payment for the Placing Shares (together with
any interest chargeable thereon) may be taken by any of the
Company, the Nominated Adviser or the Joint
Bookrunners in any jurisdiction in which the relevant Placee
is incorporated or in which any of its securities have a quotation
on a recognised stock exchange.
The foregoing representations,
warranties, agreements, undertakings, acknowledgements and
confirmations are given for the benefit of the Company as well as
the Nominated Adviser and the Joint Bookrunners, and are
irrevocable.
The agreement to allot and issue
Placing Shares to Placees (and/or to persons for whom such Placee
is contracting as agent) free of stamp duty and stamp duty reserve
tax in the United Kingdom relates only to their allotment and issue
to Placees, or such persons as they nominate as their agents,
direct from the Company for the Placing Shares in question. Such
agreement also assumes that the Placing Shares are not being
acquired in connection with arrangements to issue depositary
receipts or to issue or transfer the Placing Shares into a
clearance service. If there are any such arrangements, or the
settlement relates to any other dealing in the Placing Shares,
stamp duty or stamp duty reserve tax or other similar taxes may be
payable, the Placee agrees that it shall be responsible for such
stamp duty or stamp duty reserve tax and none of the Company,
the Nominated Adviser or the Joint
Bookrunners will be responsible for such stamp duty or stamp
duty reserve tax. The Placees shall indemnify the Company,
the Nominated Adviser and the Joint
Bookrunners on an after-tax basis for any stamp duty or
stamp duty reserve tax paid by them in respect of any such
arrangements or dealings. If this is the case, each Placee should
seek its own advice and notify the relevant Joint
Bookrunner accordingly. Placees are advised to consult with
their own advisers regarding the tax aspects of the subscription
for Placing Shares.
The Company, the Nominated Adviser
and the Joint Bookrunners are not liable to bear any transfer taxes
that arise on a sale of Placing Shares subsequent to their
acquisition by Placees or for transfer taxes arising otherwise than
under the laws of the United Kingdom. Each Placee should,
therefore, take its own advice as to whether any such transfer tax
liability arises and notify the relevant Joint Bookrunner
accordingly. Furthermore, each Placee agrees to indemnify on an
after-tax basis and hold each of the Nominated Adviser, the Joint
Bookrunners and the Company and their respective affiliates and to
hold harmless each of the Nominated Adviser, the Joint Bookrunners
and the Company and their respective affiliates from any and all
interest, fines or penalties in relation to stamp duty, stamp duty
reserve tax and all other similar duties or taxes to the extent
that such interest, fines or penalties arise from the default or
delay of that Placee or its agent.
In addition, Placees should note
that they will be liable for any stamp duty and all other stamp,
issue, securities, transfer, registration, documentary or other
duties or taxes (including any interest, fines or penalties
relating thereto) payable outside the United Kingdom by them or any
other person on the acquisition by them of any Placing Shares or
the agreement by them to acquire any Placing Shares.
Each Placee and any person acting on
behalf of the Placee acknowledges and agrees that the Joint
Bookrunners and any of their respective affiliates may, at their
absolute discretion, agree to become a Placee in respect of some or
all of the Placing Shares or by nominating
any connected or associated person to do so.
When a Placee or person acting on
behalf of the Placee is dealing with either Joint Bookrunner, any
money held in an account with the relevant Joint Bookrunner on
behalf of a Placee and/or any person acting on behalf of a Placee
will not be treated as client money within the meaning of the rules
and regulations of the FCA made under the FSMA. The Placee
acknowledges that the money will not be subject to the protections
conferred by the client money rules; as a consequence, this money
will not be segregated from the relevant Joint Bookrunner's money
in accordance with the client money rules and will be used by the
relevant Joint Bookrunner in the course of its own business and the
Placee will rank only as a general creditor of the relevant Joint
Bookrunner.
The rights and remedies of the Joint
Bookrunners and the Company under these terms and conditions are in
addition to any rights and remedies which would otherwise be
available to each of them and the exercise or partial exercise or
partial exercise of one will not prevent the exercise of
others.
Shore Capital is authorised and
regulated by the FCA in the United Kingdom and is acting
exclusively for the Company and no one else in connection with the
Placing, and Shore Capital will not be responsible to anyone
(including any Placees) other than the Company for providing the
protections afforded to its clients or for providing advice in
relation to the Placing or any other matters referred to in this
Announcement.
Panmure Liberum Limited is
authorised and regulated by the FCA in the United Kingdom and is
acting exclusively for the Company and no one else in connection
with the Placing, and Panmure Liberum will not be responsible to
anyone (including any Placees) other than the Company for providing
the protections afforded to its clients or for providing advice in
relation to the Placing or any other matters referred to in this
Announcement.
All times and dates in this
Announcement are references to London time and may be subject to
amendment. The relevant Joint Bookrunner shall notify the Placees
and any person acting on behalf of the Placees of any
changes.
No statement in this Announcement is
intended to be a profit forecast or estimate, and no statement in
this Announcement should be interpreted to mean that earnings per
share of the Company for the current or future financial years
would necessarily match or exceed the historical published earnings
per share of the Company.
The Placing Shares to be issued
pursuant to the Placing will not be admitted to trading on any
stock exchange other than the AIM market of the London Stock
Exchange.
Neither the content of the Company's
website nor any website accessible by hyperlinks on the Company's
website is incorporated in, or forms part of, this
Announcement.
DEFINITIONS
The following definitions apply
throughout this Announcement unless the context otherwise
requires:
"Acquisition"
the proposed acquisition by the Company of the
entire issued share capital of CSi Palletising, pursuant to the
terms of the Acquisition Agreement;
"Acquisition
Agreement"
the conditional acquisition agreement dated 30
September 2024 between Mpac Bidco and the Sellers, further details
of which are set in the Acquisition Announcement;
"Acquisition
Announcement"
the announcement by the Company of the Acquisition
on 1 October 2024;
"Admission"
Admission of the New Ordinary Shares to trading on
AIM becoming effective in accordance with Rule 6 of the AIM
Rules;
"AIM"
AIM, the market of that name operated by the
London Stock Exchange;
"AIM
Rules"
the 'AIM Rules for Companies' published by the
London Stock Exchange (as amended from time to time);
"Announcement"
this announcement, including the
Appendix;
"Appendix"
the appendix to this Announcement;
"Bookbuild"
the accelerated bookbuilding process in respect of
the Placing to be carried out by the Joint Bookrunners on behalf of
the Company;
"Bookbuild
Platform"
the online capital markets platform developed by
BB Technology Limited;
"Business
Day"
any day (excluding Saturdays and Sundays) on which
banks are generally open in London for normal banking
business;
"Circular"
the circular to be sent or made available by the
Company to its Shareholders on or around the Business Day following
this Announcement enclosing the Notice of General
Meeting;
"Company" or "Mpac"
Mpac Group plc, a company incorporated and registered in England
and Wales with registered number 00124855;
"Companies Act"
the Companies Act 2006 (as amended from time to
time);
"CREST"
the relevant system (as defined in the CREST
Regulations) in respect of which Euroclear is the operator (as defined in those regulations) which
facilitates the transfer of title to shares in uncertificated
form;
"CREST
Regulations"
the Uncertificated Securities Regulations 2001
(S.I. 2001 No. 3755) (as amended from time to time);
"CSi Palletising"
Elstar International B.V., a private limited liability company
incorporated under the laws of the Netherlands, registered with the
Dutch trade register under number 17202065, and which operates
under the name 'CSi Palletising';
"Directors"
the directors of the Company;
"Euroclear"
Euroclear UK & International Limited, the
operator of CREST;
"Existing Ordinary Shares"
21,533,773 ordinary shares of £0.25 (25 pence)
each in the capital of the Company in issue at the date of this Announcement, all of which are admitted to trading on
AIM;
"Facilities
Agreement"
the facilities agreement between, amongst others,
the Company (as borrower) and HSBC UK Bank plc (as
lender), further details of which are set
out in the Acquisition Announcement;
"FCA"
the UK Financial Conduct Authority;
"FCA
Handbook"
the rules and guidance of the FCA published as the
FCA Handbook as from time to time amended;
"Final
Date"
8.00 a.m. on 28 October 2024;
"FSMA"
the Financial Services and Markets Act 2000 (as
amended from time to time);
"Fundraising"
the Placing and the Retail Offer;
"General
Meeting"
the general meeting of the Company to be held at 2
Argosy Court, Coventry, CV3 4GA at 9.00 a.m. on 18 October 2024 (or
any adjournment thereof), notice of which will be set out at the
end of the Circular;
"Group"
the Company, its subsidiaries and its subsidiary
undertakings (each as defined in the Companies Act) as at the date
of this Announcement;
"ISIN"
International Securities Identification
Number;
"Issue
Price"
400 pence per New Ordinary Share;
"Joint
Bookrunners"
SCS and Panmure Liberum;
"London Stock
Exchange"
London Stock Exchange plc;
"Mpac Bidco"
Mpac Bidco B.V., a private limited liability company incorporated
under the laws of the Netherlands, registered with the Dutch trade
register under number 94964823 and which was incorporated for the
purposes of the Acquisition;
"New Ordinary
Shares"
together, the Placing Shares and the Retail Offer
Shares;
"Nominated
Adviser"
SCC, the Company's nominated adviser for the
purposes of the AIM Rules;
"Notice of General
Meeting"
the notice convening the General Meeting which
will be set out at the end of the Circular;
"Ordinary
Shares"
the ordinary shares of £0.25 (25 pence) each in
the capital of the Company;
"Panmure
Liberum"
Panmure Liberum Limited, the Company's joint
broker and joint bookrunner;
"Placee"
any person who has agreed to subscribe for Placing
Shares pursuant to the Placing;
"Placing"
the conditional placing of the Placing Shares by
SCS and Panmure Liberum, as agents on behalf of the Company,
pursuant to the Placing Agreement, further details of which are set
out in this Announcement;
"Placing
Agreement"
the conditional agreement dated 1 October 2024
between: (i) SCC; (ii) SCS; (iii) Panmure Liberum; and (iv) the
Company, relating to the Placing, further details of which are set
out in this Announcement;
"Placing
Shares"
7,250,000 new Ordinary Shares to be issued in
connection with the Placing;
"Registrar"
Link Group Limited, the Company's
registrar;
"Regulatory Information Service"
a regulatory information service operated by the London Stock
Exchange as defined in the AIM Rules;
"Resolutions"
the shareholder resolutions to be set out in the
Notice of General Meeting to be proposed at the General Meeting to
grant the Directors the authority to allot and issue the New
Ordinary Shares on a non-pre-emptive basis;
"Retail Investors"
retail Shareholders, who
are resident in the United Kingdom, and are a customer of one of
the intermediaries operating through the Bookbuild
Platform;
"Retail
Offer"
the separate offer by the Company of the Retail
Offer Shares, through the Bookbuild Platform, for Retail
Investors;
"Retail Offer
Shares"
up to 250,000 new Ordinary Shares to be issued,
conditional on Admission, in connection with the Retail
Offer;
"SCC"
Shore Capital and Corporate Limited, the Company's
nominated adviser for the purposes of the AIM Rules;
"SCS"
Shore Capital Stockbrokers Limited, the Company's
joint broker and joint bookrunner;
"Securities Act"
the United States Securities Act of 1933, as amended;
"Sellers"
Csitsme B.V., Aaseck B.V. and Lust4life Holding
B.V.;
"Shareholders"
holders of the Ordinary Shares of the Company from
time to time;
"Shore
Capital"
SCC and/or SCS as the case may be;
"UK"
the United Kingdom of Great Britain and Northern
Ireland;
"UK
MAR"
the Market Abuse Regulation (Regulation 596/2014)
(as it forms part of UK domestic law by virtue of the European
Union (Withdrawal) Act 2018, as amended);
"uncertificated
form"
Ordinary Shares recorded on the share register as
being held in uncertificated form in CREST and title to which, by
virtue of the CREST Regulations, may be transferred within the
CREST settlement system; and
"US" or
"USA"
the United States of America, each State thereof
(including the District of Columbia), its territories, possessions
and all areas subject to its jurisdiction.